Newsmeme!
Discover News you didn't know existed
Screening Assay
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Novel Human Stem Cell-based Model Of Amyotrophic Lateral Sclerosis Opens Doors For Rapid Drug Screening
Published December 4, 2008, 6:42 am, Science Daily
Long thought of as mere bystanders, astrocytes are crucial for the survival and well-being of motor neurons, which control voluntary muscle movements. In fact, defective astrocytes can lay waste to motor neurons and are the main suspects in the muscle-wasting disease amyotrophic lateral sclerosis.
Researchers develop human embryonic stem cell-based system for modeling ALS
Published December 3, 2008, 8:20 pm, News-Medical-Net
Long thought of as mere bystanders, astrocytes are crucial for the survival and well-being of motor neurons, which control voluntary muscle movements.
CytRx Unveils Clinical Development Plan For Pipeline Assets
Published December 3, 2008, 8:13 am, PharmaceuticalOnline
CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug candidates tamibarotene and INNO-206, which the Company believes offer the greatest mix of near-term and medium-term revenue potential among its clinical assets.
CytRx Unveils Clinical Development Plan for Pipeline Assets
Published December 3, 2008, 6:03 am, Centre Daily Times
CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug candidates tamibarotene and INNO-206, which the Company believes offer the greatest mix of near-term and medium-term revenue potential among its clinical assets. CytRx will pursue partnerships to advance the clinical development of INNO-406 ...
Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical ...
Published December 2, 2008, 1:32 pm, PR Newswire via Yahoo! Finance
Transgenomic, Inc. and Power3 Medical Products, Inc. today announced that Transgenomic has signed a letter of intent to acquire exclusive rights for Power3 Medical's Neurodegenerative Biomarkers, which include NuroPro®, a proposed diagnostic for Alzheimer's and Parkinson's disease.
BioTrove, Gene Express to Co-Market Novel Standardized Genetic Profiling Test
Published December 2, 2008, 7:04 am, Centre Daily Times
BioTrove Inc. and Gene Express, Inc. today announced an exclusive co-marketing agreement to test market a standardized genetic profiling test for indicators of lung cancer risk. Supported by a two-year National Institutes of Health (NIH) grant, the new profiling test combines BioTrove’s OpenArray ® nanofluidic polymerase chain reaction (PCR) technology platform, Gene Express standards for ...
BioTrove, Gene Express to Co-Market Novel Standardized Genetic Profiling Test
Published December 2, 2008, 6:30 am, Business Wire via Yahoo! Finance
WOBURN, Mass. & WILMINGTON, N.C.----BioTrove Inc. and Gene Express, Inc. today announced an exclusive co-marketing agreement to test market a standardized genetic profiling test for indicators of lung cancer risk.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |